Company / EPS (Diluted)
Zoetis EPS (Diluted) History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Diluted)
$5.07
FY2025
5-year range
$3.11 / $5.07
FY2021-FY2025
Trend
+12.9%
vs FY2024
Sector context
#11 of 204
Health Care
What the data says
Among 204 Health Care companies, Zoetis is in the top 5% for eps (diluted). EPS (Diluted) has increased for 8 consecutive years, from $0.68 in FY2017 to $5.07 in FY2025.
Based on SEC 10-K filings.
5.07 in FY2025 with a 5-year CAGR of +11.6%. Top quartile in the Health Care sector.
Improved from $4.27 to $5.07 over the past 2 years.
Health Care sector context is included.
EPS (Diluted) over time
Growth rates
- 3-Year CAGR
- +14.0%
- 5-Year CAGR
- +11.6%
- 10-Year CAGR
- -
Sector benchmark
Top 5% in Health CareTop 5% of 204This company $5.07 Sector average -$0.89
▼
+666.5% above sector average
Key checks
Key Insights
- Zoetis's eps (diluted) has grown for 8 consecutive years.
- In FY2025, eps (diluted) increased 12.9% year-over-year.
- Ranks #11 out of 204 companies in the Health Care sector.
- Lowest eps (diluted) in the period was in FY2017.
Company context
Key Data Points
- Strong profit margin: 28.2%
- Strong return on equity: 49.1%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Diluted)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | $5.07 | +12.9% |
| FY2024 | $4.49 | +5.2% |
| FY2023 | $4.27 | +24.9% |
| FY2022 | $3.42 | +10.0% |
| FY2021 | $3.11 | +6.1% |
| FY2020 | $2.93 | +67.4% |
| FY2019 | $1.75 | +6.1% |
| FY2018 | $1.65 | +142.6% |
| FY2017 | $0.68 | -41.4% |
| FY2016 | $1.16 | +14.9% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026